Logo

validation

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform

The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.

With CellPhenomics Deal, Indivumed to Offer AI-Driven Drug Target Validation
Premium

A €4.3 million EU grant is supporting the German firms' work on AI technology to accelerate precision oncology.

Indivumed, CellPhenomics Partner on Cancer Drug Target Research

The two German companies will share tumor data for AI-based in silico target discovery and in vitro validation.

MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics

As part of the initiative, MDIC will manufacture, validate, and distribute reference samples to support the validation of NGS-based cancer diagnostics.

Bioinformatics Method Could Improve Detection of Off-Target CRISPR Activity
Premium

Israeli researchers have developed CRISPector, which separates signal from noise better than earlier quality-control tools, a new paper shows.

May 10, 2021

Euformatics Signs Distribution Deal With Saudi Arabia's Al-Jeel

Apr 27, 2021

Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D

Nov 17, 2020

NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development

Oct 5, 2020

Team Shows Diagnostic Potential for Oxford Nanopore SARS-CoV-2 Assay, Calls for Improvements
Premium

Sep 10, 2020

Helio Health Collaboration Aims to Evaluate Liquid Biopsy Test for Liver Cancer

Sep 2, 2020

BloodPAC Publishes Analytical Validation Protocols for NGS Liquid Biopsy Assay Development

Aug 5, 2020

Scipher Medicine to Launch PrismRA Anti-TNF Response Predictor Following Positive Data Publication
Premium

Mar 24, 2020

HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch
Premium

Nov 7, 2019

PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study

Oct 18, 2019

Biocept Publishes Full Analytical Validation Data for Target Selector ctDNA Assays
Premium

Jun 24, 2019

Gene Expression Signature Under Development Predicts Lung Cancers Likely to Spread to Brain
Premium

May 24, 2019

Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays
Premium

Apr 10, 2019

Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database

Mar 28, 2019

MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer
Premium

Feb 7, 2019

Agiomix to Validate Biocept Target Selector Liquid Biopsy Kits

Jan 30, 2019

OncoCyte Readies Lung Cancer Test for Launch, Previews New Platform Validation Data
Premium

Jan 24, 2019

Noninvasive Prostate Cancer MDx Test Enters Validation Phase After Initial Results Published in JCO
Premium

May 15, 2018

Counsyl Researchers Report Validation of Expanded Carrier Screen

Apr 13, 2018

Clinically Validated NGS Assays Miss Challenging But Important Variants, Study Finds

Apr 2, 2018

OncoCyte Q4 Net Loss Widens as Lung Cancer Test Validation Continues

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.